Business Context and Reporting Period
This Form 8-K Current Report was filed by Aikido Pharma Inc. (not Dominari Holdings Inc.) on April 13, 2021. The report discloses a change in the registrant's certifying accountant. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol "AIKI".
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
- Dismissal of Auditor: On April 8, 2021, the Company dismissed Marcum, LLP as its independent registered public accounting firm, effective immediately.
- Engagement of New Auditor: On April 7, 2021, the Company engaged WithumSmith+Brown, PC as its new independent registered public accounting firm.
- Audit History: The reports issued by Marcum for the years ended December 31, 2020, and 2019 contained no adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles.
- Disagreements: The Company reported no disagreements with Marcum on accounting principles, practices, financial statement disclosures, or auditing scope/procedures during the recent fiscal years or through the date of the report.
- Consultations: The Company reported no consultations with Withum regarding accounting principles, audit opinions, or matters involving disagreements or reportable events prior to their engagement.
Guidance, Outlook, and Risks
This filing does not contain management guidance, financial outlook, or specific risk factors beyond the standard disclosure of the auditor change. The filing includes a letter from Marcum, LLP (Exhibit 16.1) addressed to the SEC stating whether they agree with the Company's disclosures regarding the dismissal.
Investor Verification Checklist
- Verify the reasons for the dismissal of Marcum, LLP, as they are not explicitly detailed in the body of this 8-K.
- Review Exhibit 16.1 (Marcum's letter to the SEC) to confirm the auditor's stance on the dismissal and any potential undisclosed disagreements.
- Confirm the transition timeline between the dismissal of Marcum and the engagement of WithumSmith+Brown, PC.
- Check subsequent filings (e.g., 10-K or 10-Q) for the first financial statements audited by the new firm, WithumSmith+Brown, PC.